IT turns out there’s more to your bum than meets the eye – and we’re not just talking about those backsides hitting the ...
The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
Eli Lilly posts robust Q4 earnings as Mounjaro and Zepbound sales more than double, lifting full-year revenue by 32% ...
The human microbiome market share is expected to reach US$ 4.85 billion by 2031, driven by increased investments in research, ...